mizuho's jared holz talks roche shares surging on glp-1 data
Published 1 month ago • 1.8K plays • Length 5:53
Download video MP4
Download video MP3
Similar videos
-
7:35
eli lilly's zepbound single-dose vials will expand access to more patients: mizuho's jared holz
-
5:12
structure therapeutics is a 'no-brainer takeout' target, says mizuho's jared holz
-
5:09
biogen has been an 'uninvestable' stock for awhile, says mizuho's jared holz
-
4:13
mizuho's jared holz on finding opportunities in the biotech space
-
4:25
people are 'scratching and clawing' for negative narrative around obesity drugs: mizuho's jared holz
-
10:43
jim cramer shares his take on nvidia's quarter and wall street's reaction
-
3:09
i stand by my view to own nvidia, not trade it, says jim cramer
-
5:44
market views nvidia's incremental raises as 'less impressive', says deepwater's gene munster
-
5:47
drugs for obesity are a massive market, says mizuho's jared holz
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group
-
5:47
zealand's obesity drug shouldn't disrupt novo nordisk-eli lilly leadership: mizuho's jared holz
-
5:13
obesity drug enthusiasm can continue in 2024: mizuho's jared holz
-
0:21
economy will return to shallow growth, says mizuho securities’ steven ricchiuto
-
3:36
mizuho’s jared holz breaks down unitedhealth's q1 earnings
-
3:27
medical device companies 'clear beneficiary' following humana's warning, says mizuho's jared holz
-
6:21
novo nordisk falls after strong q1 results, mizuho's jared holz talks what's next for the company
-
3:42
mizuho expects nvidia earnings to beat expectations, says vijay rakesh
-
5:26
obesity drug supply-demand imbalance is working in novo nordisk's favor: mizuho's jared holz
-
5:05
pfizer is far behind weight loss drug race despite pill trial, says mizuho's jared holz
-
3:14
election noise may make pharmaceutical stocks 'untenable' for investors, says mizuho's jared holz
-
5:52
expectations for pfizer have been low, says mizuho's jared holz on weight-loss pill setback
-
3:15
mounjaro remains the single largest driver for eli lilly stock in the near term: mizuho's jared holz
Clip.africa.com - Privacy-policy